Phase 2 clinical trials have begun to assess the safety of brentuximab vedotin for the treatment of SLE. Also, the FDA is reviewing an application for a once-daily tofacitinib citrate tablet to treat RA…
Infection & Hospitalization in SLE
From 1996–2011, the rates of hospitalization due to serious infectious diseases in patients with systemic lupus erythematosus (SLE) increased substantially, according to new research. In a retrospective data-driven study, researchers plotted and compared hospitalization and in-hospital mortality rates of SLE and non-SLE populations, determining the trends for the five most common infections…
New Study Examines Pregnancy Risk Factors for Patients with Lupus
Important new findings show that a majority of women with inactive or stable SLE can have successful pregnancies without experiencing flares and give birth to infants who survive the neonatal period…
Rontalizumab May Help Patients with Lupus & Low Interferon Signature
In a Phase 2 study, researchers found that rontalizumab was a more effective treatment in patients with systemic lupus erythematosus who had an interferon signature metric score lower than 1.
Autoimmune Myelofibrosis: A Case Review
Diagnosis, treatment and management of AMF in Hispanic patient with lupus
Russians Mourn Iconic Rheumatologist
Valentina A. Nasonova, MD, was Renaissance figure in Russian rheumatology
Reading Rheum
Handpicked Reviews of Contemporary Literature
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE
- « Previous Page
- 1
- …
- 10
- 11
- 12